Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Respirology (Carlton, Vic.)|May 23, 2023
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosisYasutaka Mochizuka, Yuzo Suzuki, Masato Kono, et al.
Respiratory Research|October 28, 2020
Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epitheliumYosuke Kamiya, Tomoyuki Fujisawa, Mineo Katsumata, et al.
Chest|July 12, 2021
Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary FibrosisHironao Hozumi, Kensuke Kataoka, Yasuhiro Kondoh, et al.
Respirology (Carlton, Vic.)|February 26, 2019
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysisHironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 6, 2024
3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitisShusuke Yazawa, Yuzo Suzuki, Yuko Tanaka, et al.
BMC Pulmonary Medicine|July 12, 2021
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort studyYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.
Oncoimmunology|May 13, 2020
CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancerKatsuhiro Yoshimura, Yuzo Suzuki, Yusuke Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancerHideki Kusagaya, Naoki Inui, Masato Karayama, et al.
Medical Oncology (Northwood, London, England)|May 29, 2016
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapySeiichiro Suzuki, Masato Karayama, Naoki Inui, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2023
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapyYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Respirology (Carlton, Vic.)|May 23, 2023
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosisYasutaka Mochizuka, Yuzo Suzuki, Masato Kono, et al.
Respiratory Research|October 28, 2020
Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epitheliumYosuke Kamiya, Tomoyuki Fujisawa, Mineo Katsumata, et al.
Chest|July 12, 2021
Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary FibrosisHironao Hozumi, Kensuke Kataoka, Yasuhiro Kondoh, et al.
Respirology (Carlton, Vic.)|February 26, 2019
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysisHironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 6, 2024
3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitisShusuke Yazawa, Yuzo Suzuki, Yuko Tanaka, et al.
BMC Pulmonary Medicine|July 12, 2021
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort studyYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.
Oncoimmunology|May 13, 2020
CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancerKatsuhiro Yoshimura, Yuzo Suzuki, Yusuke Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancerHideki Kusagaya, Naoki Inui, Masato Karayama, et al.
Medical Oncology (Northwood, London, England)|May 29, 2016
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapySeiichiro Suzuki, Masato Karayama, Naoki Inui, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2023
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapyYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Pageof 20